View in EDS HTML Full Text PDF Full Text

Targeted β−-Particle Plus Conversion and Auger-Electron Therapy with 161Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study.

Saved in:
Bibliographic Details
Title: Targeted β−-Particle Plus Conversion and Auger-Electron Therapy with 161Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study.
Authors: Fricke, Julia G.1 (AUTHOR), Westerbergh, Frida2 (AUTHOR), McDougall, Lisa1 (AUTHOR), Favaretto, Chiara1,3 (AUTHOR), Christ, Emanuel4,5 (AUTHOR), Nicolas, Guillaume P.1,4 (AUTHOR), Geistlich, Susanne3 (AUTHOR), Schmid, David E.3 (AUTHOR), Borgna, Francesca3 (AUTHOR), Fani, Melpomeni6 (AUTHOR), Bernhardt, Peter2,7 (AUTHOR), van der Meulen, Nicholas P.3,8 (AUTHOR), Müller, Cristina3,9 (AUTHOR), Schibli, Roger3,9 (AUTHOR), Wild, Damian1,4 (AUTHOR) damian.wild@usb.ch
Source: Journal of Nuclear Medicine. Mar2026, Vol. 67 Issue 3, p416-422. 7p.
Database: Engineering Source
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: egs
DbLabel: Engineering Source
An: 192012642
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeted β<superscript>−</superscript>-Particle Plus Conversion and Auger-Electron Therapy with <superscript>161</superscript>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Fricke%2C+Julia+G%2E%22">Fricke, Julia G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Westerbergh%2C+Frida%22">Westerbergh, Frida</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McDougall%2C+Lisa%22">McDougall, Lisa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Favaretto%2C+Chiara%22">Favaretto, Chiara</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Christ%2C+Emanuel%22">Christ, Emanuel</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nicolas%2C+Guillaume+P%2E%22">Nicolas, Guillaume P.</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Geistlich%2C+Susanne%22">Geistlich, Susanne</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmid%2C+David+E%2E%22">Schmid, David E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Borgna%2C+Francesca%22">Borgna, Francesca</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fani%2C+Melpomeni%22">Fani, Melpomeni</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bernhardt%2C+Peter%22">Bernhardt, Peter</searchLink><relatesTo>2,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+der+Meulen%2C+Nicholas+P%2E%22">van der Meulen, Nicholas P.</searchLink><relatesTo>3,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Müller%2C+Cristina%22">Müller, Cristina</searchLink><relatesTo>3,9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schibli%2C+Roger%22">Schibli, Roger</searchLink><relatesTo>3,9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wild%2C+Damian%22">Wild, Damian</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<i> damian.wild@usb.ch</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Nuclear+Medicine%22">Journal of Nuclear Medicine</searchLink>. Mar2026, Vol. 67 Issue 3, p416-422. 7p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=192012642
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2967/jnumed.125.270654
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 416
    Titles:
      – TitleFull: Targeted β−-Particle Plus Conversion and Auger-Electron Therapy with 161Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fricke, Julia G.
      – PersonEntity:
          Name:
            NameFull: Westerbergh, Frida
      – PersonEntity:
          Name:
            NameFull: McDougall, Lisa
      – PersonEntity:
          Name:
            NameFull: Favaretto, Chiara
      – PersonEntity:
          Name:
            NameFull: Christ, Emanuel
      – PersonEntity:
          Name:
            NameFull: Nicolas, Guillaume P.
      – PersonEntity:
          Name:
            NameFull: Geistlich, Susanne
      – PersonEntity:
          Name:
            NameFull: Schmid, David E.
      – PersonEntity:
          Name:
            NameFull: Borgna, Francesca
      – PersonEntity:
          Name:
            NameFull: Fani, Melpomeni
      – PersonEntity:
          Name:
            NameFull: Bernhardt, Peter
      – PersonEntity:
          Name:
            NameFull: van der Meulen, Nicholas P.
      – PersonEntity:
          Name:
            NameFull: Müller, Cristina
      – PersonEntity:
          Name:
            NameFull: Schibli, Roger
      – PersonEntity:
          Name:
            NameFull: Wild, Damian
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 01615505
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of Nuclear Medicine
              Type: main
ResultId 1